Correlation Between GlaxoSmithKline PLC and Gilead Sciences
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Gilead Sciences, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Gilead Sciences.
Diversification Opportunities for GlaxoSmithKline PLC and Gilead Sciences
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Gilead is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Gilead Sciences go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Gilead Sciences
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Gilead Sciences. In addition to that, GlaxoSmithKline PLC is 1.01 times more volatile than Gilead Sciences. It trades about -0.24 of its total potential returns per unit of risk. Gilead Sciences is currently generating about 0.14 per unit of volatility. If you would invest 8,221 in Gilead Sciences on August 26, 2024 and sell it today you would earn a total of 798.00 from holding Gilead Sciences or generate 9.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Gilead Sciences
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Gilead Sciences |
GlaxoSmithKline PLC and Gilead Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Gilead Sciences
The main advantage of trading using opposite GlaxoSmithKline PLC and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Gilead Sciences vs. Eliem Therapeutics | Gilead Sciences vs. HCW Biologics | Gilead Sciences vs. Scpharmaceuticals | Gilead Sciences vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |